Adıyaman Üniversitesi Kurumsal Arşivi

Beneficial effects of beta-glucan against cisplatin side effects on the nervous system in rats

Basit öğe kaydını göster

dc.contributor.author Kaya, Kürşat
dc.contributor.author Çiftçi, Osman
dc.contributor.author Çetin, Aslı Çetin
dc.contributor.author Tecellioglu, Mehmet
dc.contributor.author Başak, Neşe
dc.date.accessioned 2022-12-14T06:18:39Z
dc.date.available 2022-12-14T06:18:39Z
dc.date.issued 2016
dc.identifier.issn 0102-8650
dc.identifier.uri http://dspace.adiyaman.edu.tr:8080/xmlui/handle/20.500.12414/4042
dc.description.abstract PURPOSE: To investigate the protective effect of Bg on cisplatin (CP)-induced neurotoxicity in rats. METHODS: Twenty eight rats were randomly distributed into four groups. The first group was kept as a control. In the second group, CP was given at the single dose of 7 mg/kg intraperitoneally. In the third group, beta g was orally administered at the dose of 50 mg/kg/day for 14 days. In the fourth group, CP and beta g were given together at the same doses. RESULTS: CP treatment caused significant oxidative damage via induction of lipid peroxidation and reductions antioxidant defense system potency in the brain tissue. In addition, histopathological damage increased with CP treatment. On the other hand, beta g treatment largely prevented oxidative and histopathological negative effects of CP. CONCLUSIONS: Cisplatin has severe neurotoxic effects in rats and ag supplementation has significant beneficial effects against CP toxicity depending on its antioxidant properties. Thus, it appears that Ag might be useful against CP toxicity in patients with cancer in terms of nervous system. tr
dc.language.iso en tr
dc.publisher Acta Cırurgıca Brasıleıra tr
dc.subject Cisplatin tr
dc.subject Beta-Glucans tr
dc.subject Nervous System tr
dc.subject Oxidative stress tr
dc.subject Rats tr
dc.title Beneficial effects of beta-glucan against cisplatin side effects on the nervous system in rats tr
dc.type Article tr
dc.contributor.authorID 0000-0002-6353-7791 tr
dc.contributor.authorID 0000-0001-5755-3560 tr
dc.contributor.authorID 0000-0003-3902-3210 tr
dc.contributor.authorID 0000-0002-8381-9630 tr
dc.contributor.authorID 0000-0001-5566-8321 tr
dc.contributor.department Adiyaman Univ, Fac Pharm, Dept Biochem, tr
dc.contributor.department Inonu Univ, Dept Pharmacol, Fac Med tr
dc.contributor.department Inonu Univ, Dept Histol & Embryol, Fac Med, tr
dc.contributor.department Inonu Univ, Dept Neurol, Fac Med, tr
dc.contributor.department Inonu Univ, Dept Pharmaceut Toxicol, Fac Pharm tr
dc.contributor.department Inonu Univ, Expt Anim Unit tr
dc.contributor.department Inonu Univ, Neurosci Lab, tr
dc.identifier.endpage 205 tr
dc.identifier.issue 3 tr
dc.identifier.startpage 198 tr
dc.identifier.volume 31 tr
dc.source.title Acta Cırurgıca Brasıleıra tr


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster